Anti-TSG101 antibodies and their uses for treatment of viral infections
US8182985B2 · kind B2 · utility
1Cited by
2References
11Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Aug 1, 2008 |
| Grant date | May 22, 2012 |
| Priority date | — |
| Expiry date | May 14, 2029 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides methods of using antibodies that bind a TSG101 protein to inhibit or reduce viral production. The invention also provides methods of using the TSG101 antibodies for the treatment of viral infections, including HIV infection. The invention further provides methods of detecting viral infected cells using TSG101 antibodies.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.